Overview
Masamitsu Maekawa practices in Japan. Maekawa is rated as an Experienced expert by MediFind in the treatment of Neuroblastoma. Their top areas of expertise are Niemann-Pick Disease, Non-Langerhans-Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma.
Their clinical research consists of co-authoring 106 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Neuroblastoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Niemann-Pick DiseaseMaekawa isElite. Learn about Niemann-Pick Disease.
- Distinguished
- HistiocytosisMaekawa isDistinguished. Learn about Histiocytosis.
- Non-Langerhans-Cell HistiocytosisMaekawa isDistinguished. Learn about Non-Langerhans-Cell Histiocytosis.
- ReticulohistiocytomaMaekawa isDistinguished. Learn about Reticulohistiocytoma.
- Experienced
- Acid Sphingomyelinase Deficiency (ASMD)
- Diabetic NephropathyMaekawa isExperienced. Learn about Diabetic Nephropathy.
- Embryonal Tumor with Multilayered Rosettes
- Familial Adenomatous PolyposisMaekawa isExperienced. Learn about Familial Adenomatous Polyposis.
- GallstonesMaekawa isExperienced. Learn about Gallstones.
- Gliomatosis CerebriMaekawa isExperienced. Learn about Gliomatosis Cerebri.